- Home
- SE vs SNY Comparison
SE vs SNY Comparison
Compare SE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SE
- SNY
- Stock Information
- Founded
- SE 2009
- SNY 1994
- Country
- SE Singapore
- SNY France
- Employees
- SE N/A
- SNY N/A
- Industry
- SE Other Consumer Services
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- SE Consumer Discretionary
- SNY Health Care
- Exchange
- SE Nasdaq
- SNY Nasdaq
- Market Cap
- SE 110.6B
- SNY 119.4B
- IPO Year
- SE 2017
- SNY N/A
- Fundamental
- Price
- SE $136.13
- SNY $50.48
- Analyst Decision
- SE Strong Buy
- SNY Buy
- Analyst Count
- SE 13
- SNY 4
- Target Price
- SE $184.84
- SNY $61.50
- AVG Volume (30 Days)
- SE 5.7M
- SNY 2.3M
- Earning Date
- SE 11-11-2025
- SNY 10-24-2025
- Dividend Yield
- SE N/A
- SNY 3.18%
- EPS Growth
- SE 1416.22
- SNY 105.93
- EPS
- SE 2.29
- SNY 8.67
- Revenue
- SE $21,037,037,000.00
- SNY $53,890,648,839.00
- Revenue This Year
- SE $34.35
- SNY $2.37
- Revenue Next Year
- SE $23.38
- SNY $6.51
- P/E Ratio
- SE $59.39
- SNY $5.80
- Revenue Growth
- SE 35.84
- SNY N/A
- 52 Week Low
- SE $99.50
- SNY $44.62
- 52 Week High
- SE $199.30
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- SE 34.70
- SNY 51.88
- Support Level
- SE $127.84
- SNY $49.14
- Resistance Level
- SE $136.93
- SNY $52.67
- Average True Range (ATR)
- SE 7.13
- SNY 0.76
- MACD
- SE -0.38
- SNY -0.22
- Stochastic Oscillator
- SE 25.51
- SNY 43.80
About SE Sea Limited each representing one
Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid C2C and B2C marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue generating game. Sea's third business, SeaMoney, provides lending, payment, digital banking, and insurance services.As of March 31, 2024, Forrest Xiaodong Li, the founder, chairman and CEO, owned 59.8% of voting power and 18.5% of issued shares. Tencent owned 18.2% of issued shares with no voting power.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.